Abstract
The purpose of this study was to estimate the computed tomography (CT) examination frequency, patient radiation exposure, effective doses and national diagnostic reference levels (NDRLs) associated with CT examinations in clinical practice. A structured questionnaire-type form was developed for recording examination frequency, scanning protocols and patient radiation exposure during CT procedures in fully equipped medical facilities across the country. The national annual number of CT examinations per 1000 people was estimated to be 3 procedures. The volume-weighted CT dose index, dose length product, effective dose and NDRLs were determined for 20 types of adult and paediatric CT examinations. Additionally, the CT annual collective effective dose and effective dose per capita were approximated. The radiation exposure during CT examinations was broadly distributed between the facilities that took part in the study. This calls for a need to develop and implement diagnostic reference levels as a standardisation and optimisation tool for the radiological protection of patients at all the CT facilities nationwide.
INTRODUCTION
The technological advances in computed tomography (CT) scanners have resulted in its recognition as a valuable diagnostic tool by many medical practitioners. Unlike conventional radiography, CT scanning leads to greater radiation exposure to patients resulting in it being the single imaging modality that contributes significantly to the collective effective dose(1). This radiation exposure to patients from CT examinations may in the long-term cause cancer(2–6). The pervasiveness of CT as well as the emergence of new scanning techniques ranging from diagnostic to guided therapeutic procedures (drainage of fluid collections, pain therapy and embolisation) raises health concerns that require adequate justification and optimisation strategies(7) especially for the developing world.
In Kenya, the number of CT scanners in direct medical use increased by over 80 % in the past decade(8). Previous studies have shown that CT examinations were performed using manufacturer-prescribed protocols, resulting in multiphase protocols and inadequate professional effort geared towards developing local optimal conditions commensurate to specific patient needs and indication(9). Because the country does not have well-established national radiation dose management strategies, the radiation exposure to patients is not adequately managed, creating a need for optimisation and patient dose monitoring, record keeping, analysis as well as tracking of the exposed individuals. The dose quantities that characterise CT patient radiation exposure like volume CT dose index (mGy) and dose length product (mGy cm) that are currently displayed by CT scanners are not always recorded nor utilised to monitor optimisation of CT practice. This study was undertaken to demonstrate how operational data collection could be used to achieve a comprehensive review of CT imaging protocols that is both efficient and effective in the radiological protection of CT patients.
METHODOLOGY
CT examination frequency
In 2012, 30 CT facilities operating in the country were requested to participate on a voluntary basis in this study and in addition to fill an annual CT examination survey form supplied to all of them by the Department of Radiology at the Kenyatta National Hospital (A national referral, teaching and research hospital in Nairobi, Kenya). The survey data were received from 15 of the CT facilities representing 50 % coverage of all facilities in the country with respect to the 20 identified types of CT scanning procedures that were performed and are considered in the study.
Patient dose survey and assessment
A structured questionnaire (Table 1) was used to record both the patient information and the CT scanner radiation exposure parameters. Out of the 15 CT facilities (50 %) that participated and provided annual CT examination frequency, only 10 facilities (33 %) provided the requisite details, namely, scanner manufacturer and model, scan length, slice thickness/beam collimation, operating conditions, exposure factors and displayed patient doses.
Table 1.
Questionnaire for CT patient parameters and exposure factors.
![]() |
The CT facilities that provided patient dose survey data had the clinical protocols validated for displayed dose measurements using T40027 CT head (16 cm diameter) and body (32 cm diameter) phantoms (PTW-Freiburg, Germany) with a calibrated Unfors Xi CT external detector instrument.
The validation of the routinely displayed dose measurements was calculated using Equations 1–4. The CT air kerma index (CTDI100) in mGy mAs−1 for the head and body phantoms was estimated from Equation 1:
| (1) |
where N is the number of the simultaneously acquired slices of nominal slice thickness T. D(z) is the dose profile on the axis of rotation (z) multiplied by a correction factor for the CT probe. The weighted CT dose index (CTDIw) in mGy mAs−1 was obtained using Equation 2. The CTDIw combines values measured at the centre (CTDI100,c) and periphery (CTDI100,p) of a standard CT dosimetry phantom for a particular tube current–exposure time product (mAs):
| (2) |
The volume CT dose index (CTDIvol) was obtained using Equation 3 in mGy per volume scanned:
| (3) |
where I is the constant slice increment in mm per gantry axial rotation.
The CT dose length product (DLP) for axial and spiral scanning for a complete CT examination was estimated using Equation 4:
| (4) |
where scan length is the product of the total number of serial or helical scans and the slice width. Effective dose (E) is estimated using Equation 5:
| (5) |
where the DLP values calculated using Equation 4 were obtained from the questionnaire records, while appropriate region-specific normalised effective dose coefficients (EDLP) values in mSv mGy−1 cm−1 were obtained from the age- and sex-specific conversion factors in reference(10) compared with the values obtained from dose coefficient factors in references(11) and(12) for composite scans. Effective dose coefficients or k-factors are used to convert DLP displayed on the CT console per examination to derive patient-effective doses. These effective dose conversion factors were derived from data averaged over many models of scanners thus being non-specific to a CT scanner. The mean effective dose per examination type was used to calculate the collective effective dose in CT. The annual collective effective dose (S) from the CT scanning examination patient population was determined for each age group as a product of mean effective dose and the total patient population per examination type(9). As a guideline for good practice, the third quartile patient dose values for each age group examination procedure irrespective of the hospital or CT scanner model were determined and proposed as the initial national diagnostic reference levels (NDRLs) for each CT procedure. In the study, the effective dose according to age and gender categories was reported but not considered NDRLs because it is not a measurable dosimetry parameter.
RESULTS
CT examination frequency
The sum total of CT examinations in the country was over 112 000 (about 0.3 % of the total population at the time) and distributed as shown in Figure 1: 77 % adults (40 % male, 37 % female) and 23 % children (13 % male, 11 % female). In children, 99 % of CT examinations were found to be distributed as follows: brain (82 %), sinuses (9 %), abdomen (4 %) and chest (4 %). In adults, 89 % of the CT examinations were found to be distributed as follows: brain (48 %), chest (19 %), abdomen (13 %) and spine (9 %).
Figure 1.
The frequency distribution of the year 2012 CT examinations and the total population in the country according to age and gender.
The analysed patient dose sample size of 3178 patients had the anatomical distribution as shown in Figure 2. The proportion of male CT brain patients was found to be 20 % higher than that of female patients, which was associated with more susceptibility to the motor vehicle accident trauma. The average weight for adults was found to be 69 kg for males and 71 kg for females, and respective gender weights for children were found to be 31 and 26 kg.
Figure 2.
The distribution of CT examinations samples for patient dose assessment (the other examinations are neck and lumbar spine for children and pelvis, computed tomography angiograph aorta, cerebral angiography, liver, temporal bones, orbits, pulmonary angiography and coronary angiography for adults).
Patient dose survey and assessment
The national quality management level or index for the CT practice was determined to be fair and the least of all the quality management performance indicators that were considered(13). Most facilities used manufacturer-installed scanning protocols without any facility optimisation efforts. Table 2 contains a summary of scanning techniques for the CT examinations of representative patients from the 33 % of the hospitals that took part in the study. Complex CT angiography examinations were performed by doctors using a standard technique in all the CT facilities. The kVp values per examination type were generally consistent, but variations were observed with respect to mAs, slice thickness and pitch.
Table 2.
Mean (range) clinically used exposure factors in the CT examinations.
| Examination | N (age—y) | kVp |
mAs |
Rotation time |
Slice thickness (mm) | Pitch |
|||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mode | Range | Mode | Range | Mean | Range | Mode | Range | Mode | Range | ||
| Child | |||||||||||
| Brain | 120 (0–1) | 120 | 100–130 | 200 | 110–415 | 0.8 | 0.4–1.5 | 5 | 2.5–5 | 0.44 | 0.44–2 |
| 140 (2–5) | 120 | 90–130 | 250 | 155–600 | 0.7 | 0.4–1.5 | 3 | 1–5 | 0.44 | 0.44–0.69 | |
| 254 (6–15) | 120 | 80–130 | 155 | 155–500 | 0.8 | 0.3–1.5 | 5 | 1–5 | 0.52 | 0.44–0.69 | |
| Chest | 10 (2–5) | 120 | 120–130 | 170 | 29–177 | 1.1 | 0.7–1.5 | 5 | 1–5 | 1 | 0.78–1.5 |
| 17 (6–15) | 120 | 120–131 | 170 | 60–250 | 1 | 0.4–1.5 | 5 | 2–5 | 2 | 0.56–2 | |
| Abdomen | 28 (3–15) | 120 | 110–120 | 160 | 70–313 | 0.8 | 0.4–1 | 5 | 1–5 | 1 | 0.94–2 |
| Sinuses | 56 (2–15) | 120 | 120–130 | 250 | 60–300 | 0.6 | 0.5–0.8 | 1 | 1–3 | 0.64 | 0.44–0.94 |
| Lumbar spine | 2 (0.5–11) | 120 | 120–130 | 130 | 80–212 | 1 | 0.4–1.5 | 5 | 2–5 | 0.96 | 0.42–1.5 |
| Neck | 3 (3–12) | 130 | 130–140 | 103 | 60–70 | 1 | 0.5–1.5 | 5 | 1–5 | 0.42 | 0.42 |
| Adult | |||||||||||
| Brain | 1234 (16–100) | 120 | 90–140 | 360 | 60–600 | 1.5 | 0.5–1.5 | 5 | 1–10 | 0.44 | 0.44–1.5 |
| Chest | 328 (16–97) | 120 | 100–140 | 250 | 40–342 | 0.75 | 0.4–1.5 | 3 | 1.5–6 | 1 | 0.8–2.0 |
| Abdomen | 486 (16–100) | 120 | 80–140 | 100 | 61–415 | 0.75 | 0.4–1.5 | 3 | 0.5–8 | 0.9 | 0.43–2.0 |
| CTA renal | 32 (20–79) | 120 | 120 | 250 | 158–500 | 0.75 | 0.4–0.75 | 2 | 1–3 | 0.94 | 0.35–1.28 |
| CT pyelogram | 55 (24–84) | 120 | 120 | 245 | 134–359 | 0.75 | 0.4–0.75 | 0.5 | 0.5–3 | 1 | 0.81–1.18 |
| Facial bones | 26 (16–49) | 120 | 120 | 300 | 250–500 | 0.5 | 0.5–0.75 | 1 | 1 | 0.64 | 0.56–0.69 |
| Sinuses | 191 (16–84) | 120 | 120–130 | 250 | 60–300 | 0.75 | 0.4–1 | 1 | 0.8–1 | 0.44 | 0.44–1 |
| Lumbar spine | 48 (23–79) | 130 | 100–140 | 120 | 77–351 | 1 | 0.5–1.5 | 2 | 2–10 | 1.5 | 0.42–2.0 |
| Neck | 33 (23–70) | 120 | 120–130 | 100 | 18–290 | 0.75 | 0.4–1.5 | 5 | 0.5–5 | 0.94 | 0.94–1.5 |
| Pelvis | 15 (22–83) | 120 | 120–130 | 250 | 110–335 | 0.75 | 0.75–1 | 2 | 1–3 | 0.69 | 0.61–1.17 |
| Cervical spine | 37 (17–73) | 120 | 120–140 | 235 | 90–462 | 0.75 | 0.5–1 | 2 | 1–2 | 0.42 | 0.42–1 |
| Celebral angio | 10 (19–67) | 120 | 120 | 300 | 300–569 | 0.75 | 0.75 | 0.5 | 0.3–2 | 0.92 | 0.2–0.92 |
| Pulmonary angio | 2 (33–38) | 120 | 120 | 194 | 178–211 | 0.75 | 0.75 | 1 | 1 | 1.1 | 1.1 |
| CTA entire aorta | 11 (22–78) | 120 | 120 | 230 | 174–287 | 0.75 | 0.75 | 1 | 1 | 1.1 | 1–1.1 |
| BMD | 23 (29–88) | 120 | 120 | 200 | 200–250 | 0.75 | 0.75 | 0.5 | 0.5 | 0.64 | 0.64 |
| Coronary angio | 2 (78–80) | 120 | 120 | 276 | 100–451 | 0.4 | 0.4 | 1 | 1 | 0.2 | 0.2 |
| Liver | 6 (37–63) | 120 | 120 | 218 | 125–288 | 0.75 | 0.75 | 3 | 1.5–3 | 1 | 1–1.14 |
| Orbits | 4 (39–49) | 120 | 120 | 300 | 250–400 | 0.5 | 0.5–0.8 | 0.5 | 0.3–0.5 | 0.64 | 0.6–0.7 |
| Temporal bones | 5 (16–52) | 120 | 120–140 | 349 | 349 | 0.75 | 0.75 | 0.3 | 0.3 | 0.35 | 0.35 |
| N = no. of patients. | |||||||||||
CTA, computed tomography angiograph.
Table 3 indicates that the measured CTDIvol and DLP on a phantom for head, chest and abdomen, clinical exposure parameters and measured results were within acceptance level when compared with the values displayed on the scanner console. Table 4 is a record of measured patient dose with respect to CTDIvol, DLP and E for the CT procedures reported. The values were corrected based on the measurements shown in Table 3. The CTDIvol for brain examinations were below the DRLs in the literature except for 0–1-year-old children that were 10 % above. The DLP and E values for adult lumbar spine examinations were 10 % below and 20 % above the DRLs, respectively. The mean patient dose lower than the DRLs was 50 % for CTDIvol, 27 % for DLP and 11 % for effective dose. The CTDIvol variations were attributed to the slice thickness in the scanning protocols employed, while for DLP, it was associated to the patient body region and scan length. The suboptimal protocols were associated with the operator errors (wrong protocol selection), acquisition errors and patient induced errors resulting in additional scanning as well as express use of manufacturer-provided CT protocols. In children, the DRLs in the literature covered 55 % of the procedures considered in this study, whereas for adults, the coverage was 26 %. In children, the results showed that 60, 40 and 20 % were below the DRLs for CTDIvol, DLP and E, respectively. The figures for adults were 60, 20 and 20 %, respectively. In the study, the average collective dose per scanner was estimated to be 21 person-Sievert per year, which was larger than the 19 person-Sievert per year obtained in a previous study(8). For the CT scanner, three examinations that delivered the largest collective effective dose to adults in decreasing order were abdomen, chest and brain. The corresponding examinations in children were brain, abdomen and chest.
Table 3.
Comparison of measured and displayed CTDIvol and DLP per CT scanner.
| Philips Brilliance 6 |
Philips Brilliance 64 |
Philips Brilliance 16 |
Philips Brilliance 16 |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Clinical head | Clinical chest | Clinical abdomen | Clinical head | Clinical chest | Clinical abdomen | Clinical head | Clinical chest | Clinical abdomen | Clinical head | Clinical chest | Clinical abdomen | |
| Phantom employed | Head phantom | Body phantom | Body phantom | Head phantom | Body phantom | Body phantom | Head phantom | Body phantom | Body phantom | Head phantom | Body phantom | Body phantom |
| Scan type: axial/helical (pitch) | Axial | Axial helix | Helical | Axial | Axial | Axial/helical | Axial | Axial | Helical | Axial helical | Axial helical | Axial helical |
| Technical factors | ||||||||||||
| Pitch | 0.65 | 0.8 | 0.9 | 0.67 | 1 | 1.142 | 1 | 1 | 0.94 | 1 | 1 | 0.94 |
| kVp | 120 | 120 | 120 | 120 | 120 | 120 | 120 | 120 | 120 | 120 | 120 | 120 |
| Time | 1.5 | 0.75 | 0.75 | 0.75 | 0.5 | 0.75 | 1.5 | 0.75 | 0.75 | 1.14 | 0.53 | 0.8 |
| mAs | 415 | 250 | 250 | 399 | 226 | 312 | 600 | 200 | 250 | 399 | 249 | 300 |
| Display FOV | 200 | 300 | 300 | 210 | 350 | 339 | 250 | 300 | 375 | 171 | 325 | 325 |
| Detector size | 1.5 | 1.5 | 1.5 | 0.625 | 0.625 | 0.625 | 0.75 | 0.6 | 1.5 | 16 | 16 | 16 |
| No. of detector rings | 6 | 6 | 6 | 64 | 2 | 64 | 16 | 2 | 16 | 0.75 | 0.75 | 1.5 |
| Scan time (sec) | 7.5 | 3.2 | 2.9 | 3.5 | 0.5 | 2.5 | 1.8 | 0.75 | 3 | 1.8 | 0.75 | 3 |
| Scan length (mm) | 30.1 | 30.6 | 31.2 | 125.7 | 1.2 | 81 | 12 | 1.2 | 94.4 | 12 | 1.2 | 94.4 |
| Mean measured dose (mGy) | ||||||||||||
| Central | 17.3 | 3.4 | 3.6 | 42 | 0.2 | 11.6 | 9.6 | 0.2 | 7.6 | 12 | 0.2 | 0.4 |
| North | 15.8 | 5.9 | 6.7 | 45.3 | 0.5 | 21.5 | 11.9 | 0.3 | 14.7 | 14 | 0.7 | 0.7 |
| East | 18.7 | 7.4 | 8.4 | 44.4 | 0.4 | 18.5 | 10.4 | 0.3 | 14.1 | 12 | 0.6 | 1.1 |
| South | 21.2 | 6.6 | 7.8 | 43.9 | 0.3 | 22.1 | 9.4 | 0.3 | 15.8 | 12 | 0.5 | 1 |
| West | 19 | 5.7 | 7 | 45.1 | 0.4 | 22.8 | 10.8 | 0.3 | 17.4 | 13 | 0.6 | 1 |
| Results | ||||||||||||
| CTDIvol (mGy)—measured | 62 | 17.7 | 19.8 | 51.7 | 27.3 | 19.4 | 85.7 | 20.8 | 14.5 | 77.6 | 21 | 24 |
| CTDIvol—displayed on console | 65.6 | 20 | 20 | 51.1 | 34.1 | 20.2 | 91.3 | 20 | 17.6 | 65.6 | 20 | 20 |
| CTDIvol (meas.—display)—% diff. | −5.5 | −11.5 | −1.0 | 1.2 | −19.9 | −4.0 | −6.1 | 4.0 | −17.6 | 18.3 | 5.0 | 20.0 |
| DLP (mGy cm)—measured | 186.3 | 53.9 | 61.7 | 649.7 | 3.3 | 157.5 | 102.8 | 2.5 | 137 | 233 | 64 | 75 |
| DLP—displayed on console | 192.7 | 61 | 62.4 | 715 | 4.1 | 303 | 109.6 | 2.4 | 156 | 193 | 61 | 62 |
| DLP (meas.—display)—% diff. | −3.3 | −11.6 | −1.1 | −9.1 | −19.5 | −48.0 | −6.2 | 4.2 | −12.2 | 20.7 | 4.9 | 21.0 |
| Siemens Somatom Spirit |
Philips Brilliance 40 |
Siemens Somatom Emotion 6 |
Siemens Emotion Duo |
|||||||||
| Clinical head | Clinical chest | Clinical abdomen | Clinical head | Clinical chest | Clinical abdomen | Clinical head | Clinical chest | Clinical abdomen | Clinical head | Clinical chest | Clinical abdomen | |
| Phantom employed | Head phantom | Body phantom | Body phantom | Head phantom | Body phantom | Body phantom | Head phantom | Body phantom | Body phantom | Head phantom | Body phantom | Body phantom |
| Scan type: axial/helical(pitch) | Axial | Axial helix | Axial helix | Axial helix | Axial helix | Axial helix | Axial | Axial | Helical | Axial | Axial | Helical |
| Technical factors | ||||||||||||
| Pitch | 1 | 1.85 | 1.6 | 0.68 | 0.78 | 1.13 | 1 | 1 | 1 | 1 | 1 | 1 |
| kVp | 130 | 130 | 130 | 120 | 120 | 120 | 130 | 130 | 130 | 130 | 130 | 110 |
| Time | 1.5 | 1 | 1 | 0.75 | 0.75 | 0.75 | 1.5 | 0.8 | 0.8 | 1.5 | 2.4 | 1.8 |
| mAs | 220 | 78 | 100 | 300 | 244 | 196 | 250 | 122 | 100 | 260 | 40 | 70 |
| Display FOV | 200 | 358 | 359 | 171 | 363 | 363 | 200 | 350 | 350 | 200 | 350 | 350 |
| Detector size | 5 | 5 | 5 | 0.625 | 0.625 | 0.625 | 2 | 2 | 2 | 2.5 | 4 | 4 |
| No. of detector rings | 2 | 2 | 2 | 40 | 40 | 40 | 6 | 6 | 6 | 2 | 5 | 5 |
| Scan time (sec) | 1.5 | 6 | 9.1 | 3.9 | 3.5 | 2.5 | 3.4 | 2.3 | 2 | 1.5 | 2.4 | 1.8 |
| Scan length (mm) | 10 | 30 | 45.5 | 44.1 | 91.5 | 95.1 | 12 | 42.8 | 30 | 5 | 20 | 20 |
| Mean measured dose (mGy) | ||||||||||||
| Central | 3.8 | 2.1 | 2.7 | 29.2 | 7.6 | 6.4 | 6.2 | 3.2 | 4.9 | 2.6 | 0.8 | 0.57 |
| North | 4.1 | 3.9 | 5.7 | 34.7 | 19.9 | 11.2 | 8.3 | 6.6 | 5.8 | 3.3 | 1.25 | 1.27 |
| East | 4 | 4 | 4.9 | 33.3 | 17.1 | 10.8 | 6.7 | 6.1 | 5.7 | 3.2 | 1.29 | 1.36 |
| South | 4 | 4.5 | 4.2 | 29.8 | 12.6 | 15.6 | 6 | 4.9 | 7 | 3.6 | 1.28 | 1.52 |
| West | 4.2 | 4.3 | 5.5 | 31.7 | 13 | 11.7 | 5.6 | 5.6 | 5.7 | 3.1 | 1.38 | 1.21 |
| Results | ||||||||||||
| CTDIvol (mGy)—measured | 39.6 | 6.3 | 8.9 | 35.6 | 18 | 10.9 | 54.2 | 14.4 | 18.8 | 61.7 | 5.6 | 5.4 |
| CTDIvol—displayed on console | 42.1 | 7.4 | 9.5 | 40.9 | 17.1 | 13.7 | 58.8 | 14 | 13.2 | 59.7 | 4.5 | 4.7 |
| CTDIvol (meas.—display)—% diff. | −5.9 | −14.9 | −6.3 | −13.0 | 5.3 | −20.4 | −7.8 | 2.9 | 42.4 | 3.4 | 24.4 | 14.9 |
| DLP (mGy cm)—measured | 42.1 | 35.5 | 40.6 | 156.9 | 164.8 | 103.2 | 65 | 61.5 | 56.3 | 29.9 | 11.2 | 11 |
| DLP—displayed on console | 42 | 39 | 48 | 154 | 153 | 130 | 71 | 57 | 55 | 35 | 13 | 15 |
| DLP (meas.—display)—% diff. | 0.2 | −9.0 | −15.4 | 1.9 | 7.7 | −20.6 | −8.5 | 7.9 | 2.4 | −14.6 | −13.8 | −26.7 |
FOV, field of view.
Table 4.
CT mean (range) patient dose values compared with DRLs.
| Exam. | Age (y) | CTDIvol (mGy) | NDRL (mGy) | DRL (mGy) | DLP in (mGy cm) | NDRL (mGy cm) | DRL (mGy cm) | E (mSv) | 3Q (mSv) | 3Q (mSv) | E values in literature |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Child | |||||||||||
| Brain | 0–1 | 33 (16–66) | 38 | 33(14), 20(15), 35(16), 31(17, 18) | 739 (163–2959) | 1005 | 390(14), 270(15, 16), 333(17, 18), 300(19), 820(20) |
4 (1–15) | 6 | 3(16) | 2.5 (1.8–3)(16), a |
| 2–5 | 41 (7–91) | 50 | 40(14), 30(15, 16), 45(16), 47(17, 18) | 1072 (135–3146) | 1395 | 520(14), 420(15), 470(16), 374(17, 18), 650(21), 600(19), 1000(20) | 4 (0.5–10) | 5 | 1.9(16) | 1.5 (1.1–1.9)(16), a | |
| 11–15 | 43 (14–760 | 55 | 50(14), 40(15), 45,65(16) | 1113 (190–3052) | 1608 | 710(14), 560c, 620(16), 975(21), 750(19), 1040(20) | 3 (0.5–9) | 4 | 2(16) | 1.6 (1.3–2)(16), a | |
| Chest | 2–5 | 11 (1–12) | 11 | 5.5(14), 8(15), 13(16), 12(17, 18) | 189 (53–339) | 215 | 110(14), 200(15), 230(16), 152(17, 18) 336(21), 400(19) | 4 (1–7) | 6 | 4.1(16) | 3.6 (2.1–4.1)(16), a |
| 11–15 | 8 (2–19) | 11 | 8.5(14), 10(15), 20(16) | 363 (72–1069) | 453 | 210(14), 220(15), 370(16), 578(21), 600(19) | 9 (1–32) | 13 | 4.8(16) | 3.9 (2.3–4.8)(16), a | |
| Abdomen | 3–5 | 11 (4–22) | 11 | – | 554 (163–1652) | 765 | 250(19) | 9 (2–19) | 11 | – | – |
| Sinuses | 2–15 | 29 (12–49) | 38 | – | 468 (56–1475) | 538 | – | 3 (0.3–8) | 3 | – | – |
| Lumbar spine | 0.5–11 | 11 (5–22) | 14 | – | 326 (125–702) | 426 | – | 7 (3–16) | 10 | – | – |
| Neck | 3–12 | 7 (2–12) | 9 | – | 232 (54–422) | 322 | – | 3.8 (0.8–7) | 5 | – | – |
| Adult | |||||||||||
| Brain | 16–100 | 55 (7–112) | 61 | 65*, 100(16), #, 60(22), 69(23), 66(24) |
1274 (112–5101) | 1612 | 1050(22), 760(25, 16), *, 930(16), #, 1120(20), 1000(26), 900(27, 28) 1312(23), 940(24) |
2 (0.2–10) | 3 | 1.7(16) | 2 (0.9–4)(29)1.5 (1.2–1.7)(16), a, 1.5(28), 1.7(25) |
| Chest | 16–97 | 14 (1–40) | 19 | 10(22, 16), *, 13(16), #, 15(23) 11(24) | 709 (39–3467) | 895 | 430*, 580(16), #, 650(22), 580(20), 400(26), 520(27), 250(28), 190(25), 569(23), 390(24) | 10 (0.4–54) | 13 | 6.9(16) | 7 (4–18)(29), 5.8 (3.9–6.9)(16), a, 3.3,4(28), 3.5(25) |
| Abdomen | 16–100 | 14 (2–42) | 20 | 13*, 14(16),#, 25(22), 18(23) | 1340 (114–5666) | 1842 | 460*, 470(16),#, 300(28), 580(25), 555(23) | 21 (2–88) | 28 | 7.1(16) | 8 (3–25)(29), 5.3 (2.6–7.1)(16), a, 3.2,3.6(28), 7(25) |
| CTA renal | 20–79 | 23 (9–76) | 21 | – | 1476 (332–3765) | 2040 | – | 23 (5–61) | 32 | – | 15(29), 12.3,13.3(28) |
| CT pyelogram | 24–84 | 14 (6–25) | 18 | – | 922 (218–2941) | 1287 | 350(28) | 14 (3–51) | 18 | – | 15 (9–19)(30), (25–35)(31), 4.4,4.6(28) |
| Facial bones | 16–49 | 36 (19–76) | 38 | – | 1013 (44–2432) | 1169 | – | 2 (0.8–4) | 2 | – | – |
| Sinuses | 16–84 | 33 (11–75) | 41 | – | 550 (112–1840) | 700 | – | 1 (0.2–4) | 1 | – | – |
| Lumbar spine | 23–79 | 17 (6–43) | 20 | 12*, 14(16),#, 15(22), 42(23) |
582 (162–2261) | 712 | 900(22), 650(16, 28), 680(20), 400(26), 720(27), 300(25), 888(23) | 9 (2–30) | 12 | 8(16) | 6 (1.5–10)(29), 7.1 (5.3–8)(16), a, 6.8,7.2(28), 6.4(25) |
| Neck | 23–70 | 12 (5–20) | 16 | – | 697 (153–1572) | 1010 | 460(22), 520(20), 500(26) | 4 (0.8–8) | 5 | – | 3(29) |
| Pelvis | 22–83 | 18 (6–24) | 21 | 13*, 14(16), # | 1257 (153–3464) | 1928 | 570(22), 510*, 560(16), #, 350(20), 500(26), 540(27) | 18 (2–54) | 25 | – | 6 (3–10)(29) |
| Cervical spine | 17–73 | 27 (6–72) | 34 | – | 758 (172–1503) | 1015 | – | 4 (0.9–8) | 5 | – | – |
| Celebral angio | 19–67 | 43 (30–55) | 50 | – | 4076 (2479–5657) | 4324 | 350(28) | 8 (4–10) | 8 | – | – |
| Pulmonary angio | 33–38 | 13 (11–14) | 13 | – | 623 (334–912) | 767 | 250(28) | 12 (6–17) | 14 | – | 15 (13–40)(29), 2.8,3.4(28) |
| CTA entire aorta | 22–78 | 15 (11–19) | 18 | – | 1931 (1083–3412) | 2495 | 450(28) | 30 (11–63) | 44 | – | 5.2,5.7(28) |
| BMD | 29–88 | 16 (15–32) | 15 | – | 422 (200–1047) | 457 | – | 6.7 (3–14) | 7 | – | – |
| Coronary angio | 78–80 | 18 (7–29) | 24 | 61(23) | 423 (133–714) | 568 | 1510(20), 1000(26), 1208(23) | 6 (2–10) | 6 | – | 16 (5–32)(29), 6.4b, 11(32), c |
| Liver | 37–63 | 14 (8–19) | 18 | – | 1734 (903–2602) | 2197 | 460, 470(16) | 19 (13–27) | 23 | – | 15(29), 5.9,7.2(28) |
| Orbits | 39–49 | 38 (32–51) | 42 | – | 1943 (1146–2730) | 2258 | – | 4 (2–5) | 4 | – | – |
| Temporal bones | 16–52 | 80 (78–84) | 84 | – | 732 (391–1489) | 766 | – | 2 (0.8–3) | 2 | – | – |
CTA, computed tomography angiograph.
(–) Reference level not found.
aDose range provided as mean(2Q–3Q).
b16 Slices.
c64 Slices.
qUsed DLP conversion factors and imaging performance assessment of computed tomography scanners dose calculator, respectively.
DISCUSSION
Imaging techniques and patient doses
A CT image produces detailed clinical anatomical display of disease pathology or altered anatomy features but contributes significantly to radiation exposure to the patients. To achieve patient radiation protection in these examinations, it is essential to analyse the scanning protocols, optimise the exposure factors, assess patient dose and compare with other studies as well as reference levels(14, 23, 24, 29, 33–36). Although the CT patient exposure factors in this study (Table 2) were similar to the European recommendations(22), large and varying radiation doses were observed in the examinations involving brain, chest and lumbar spine in adults performed with the default manufacturer-setting scanning protocols. The use of thin slices may have produced high-resolution images but at a cost of higher radiation dose to the patients (Table 4). Axial scanning was the most frequently used method in adult brain scans. The tilted gantry was used by some facilities to reduce radiation dose to the radiosensitive lens of the eye(37). The majority of the adult chest, abdomen and pelvis, as well as paediatric brain scans, were performed using the helical scanning method. The study showed inadequate use of the equipment-displayed dose measurement readout during patient scan. The patient-specific information generated from the imaging equipment console display system needs to be analysed when developing optimal radiation and indication specific scanning techniques for specific CT equipment.
In the overall, 60 % of volume CT dose index and 20 % of DLP were below the diagnostic reference levels in children cases. Twenty per cent of effective dose measurements were below the reported values for children in the literature (Table 4). The respective figures for adults were similar in proportion except for the DLP, which was 40 %. The CTDIvol values were indicative of the slice thickness selected that resulted in larger radiation output when compared with the values reported in the literature(17, 16). Additionally, the larger CTDIvol values were attributed to the tube distance, beam filtrations and patient body size. The large DLP was attributed to the high CTDIvol, equipment efficiency performance and the CT scanner technological level, type or model. The larger DLP and E dose values were associated to the human factors like scanning of longer body size attainable due to the fast CT scanning technique and the prolific use of manufacturer-specified scanning protocols(7, 8, 38, 39) and the unavailability of radiologists to oversee justification and optimisation (most CT facilities had only one radiologist taking care of all the clinical reports of the imaging procedures within the facility). The 25–63 % large E values in paediatric examinations were attributed to the conversion factors used that took into consideration the children being radiosensitive, with longer life expectancy and higher radiation exposure from non-optimal CT technique on a small body size. Additionally, the prescribed head CT scans due to head trauma were done from the seventh cervical vertebrate to the head vertex. Abdominal examinations constituted the largest contribution of the collective effective dose (52 %) in adults despite its low frequency (13 %) when compared with other CT examination procedures. Overall, the high portion of CT collective effective dose was linked to the increasing CT examinations and contrast enhancement studies. There was new CT angiography (pulmonary, coronary, renal, abdominal aorta, peripheral, carotid arteries, Circles of Willis) examinations including the bone mineral density (BMD) associated with diagnosis and follow-up of osteoporosis in aging patients. CT angiography examinations were generally performed with multiple series scans involving use of contrast media, employing a delayed serial scanning technique to visualise the renal function for any pathology or insufficiencies during contrast excretion. In the evaluation of patients with a high likelihood of malignant disease, radiation dose was not a limiting factor as long as the ALARA (as low as reasonably achievable) principle was applied appropriately. Consequently, a similar split-bolus two- and three-phase CT angiography at an increased radiation dose level was justifiable for such patients.
By definition, the NDRL is the third quartile value of measured national patient dose distributions for a specific procedure, while the local diagnostic reference level (LDRL) is the mean patient dose for sampled patients at a specific CT facility or hospital radiological practice(40). Based on the findings of this study, it is recommended that the use of LDRLs is more effective for indication-specific patient dose management in low-resource countries with no well-established quality management systems. Developing countries exhibit centralised sites with specialised imaging facilities, radiologists and clinical consultants. Nationally, development and incorporation of patient dosimetry are critical in risk assessment and radiological protection of patients. CT scanning results in larger radiation dose exposure compared with other radiological imaging modalities, and therefore, there is need for a clinical indication-specific scanning protocol for dose optimisation.
CONCLUSION
The multi-factorial nature of optimisation in CT scanning requires relevant training in patient dosimetry among medical imaging professionals, automated display of patient parameters such as weight and radiation exposure and establishment of equipment efficiency performance standards. LDRLs could help facilities to address the optimisation of patient radiation dose during the rapid expansion and increasing kinds of CT examinations that are being performed. There is a need to establish customised CT facility optimisation strategies, justification and LDRLs specific to the facility performing the procedures. The CT annual collective effective dose and effective dose per capita were determined as 86 person-Sievert and 0.002 mSv in children, respectively. The equivalent values in adults are given as 682 person-Sievert and 0.02 mSv. The large patient radiation exposure in CT procedures at 30 % of all the CT facilities revealed an inconsistent pattern for optimisation of CT imaging protocols to adequately match the prevailing clinical conditions. A more comprehensive study on CT scanners should be conducted to cover all the CT scanners in use in the country to obtain a better understanding of their safe utilisation.
This study recommends the international community to lend support to developing countries to establish their national patient dosimetry and radiobiology database centres in order to manage and maintain medical exposure surveillance programmes, national X-ray examinations trends, patient dose assessment and regular X-ray equipment performance surveillance audits under the medical professional or national regulatory authority stewardship. Such a national programme will require a concerted effort from all stakeholders in the radiological practice, with the medical physicists playing the vital role in radiation exposure quantification, calibration checks of CT scanner measured dose values and patient radiation dose optimisation. The role of medical physicists in the optimisation, quality assurance and quality control of radiological equipment, especially CT scanners, is vital and needs to be adequately supported.
ACKNOWLEDGEMENTS
We sincerely thank the management and radiology staff of the CT facilities for accepting to participate in the International Atomic Energy Agency (IAEA) Project (RAF/9/033— Strengthening Radiological Protection of Patient and Medical Exposure Control) and making this study possible, and the IAEA for their support.
REFERENCES
- 1.United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR). Sources and Effects of Ionizing Radiation, Volume 1. UNSCEAR 2008 report to the general assembly with annexes. United Nations, (2010).
- 2.Einstein A. J., Henzlova M. J., Rajagopalan S. Estimating risk of cancer associated with radiation exposure from 64-slice computed tomography coronary angiography. JAMA. 298, 317–323 (2007). [DOI] [PubMed] [Google Scholar]
- 3.Berrington de Gonzalez A., Mahesh M., Kim K. P., Bhargavan M., Lewis R., Mettler F., Land C. Projected cancer risks from computed tomographic scans performed in the United States in 2007. J Arch. Intern. Med. 169, 2071–2077 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Pearce M. S., et al. Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study. Lancet. 380, 499–505 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Brenner D. J., Hall E. J. Computed tomography—an increasing source of radiation exposure. New Engl. J. Med. 357, 2277–2284 (2007). [DOI] [PubMed] [Google Scholar]
- 6.Preston D. L., Ron E., Tokuoka S., Funamoto S., Nishi N., Soda M., Mabuchi K., Kodama K. Solid cancer incidence in atomic bomb survivors: 1958–1998. Radiat. Res. 168, 1–64 (2007). [DOI] [PubMed] [Google Scholar]
- 7.International Commission on Radiological Protection (ICRP). Managing Patient Dose in Computed Tomography. ICRP Publication 87. Ann. ICRP 30(4) (2001). [DOI] [PubMed]
- 8.Wambani J. S., Korir G. K., Onditi E. G., Korir I. K. A survey of computed tomography imaging techniques and patient dose in Kenya. East Afr. Med. J. 87, 400–407 (2010). [PubMed] [Google Scholar]
- 9.Korir G. K., Wambani J. S., Korir I. K. Patient doses using multidetector computed tomography scanners in Kenya. Radiat. Prot. Dosim. 151, 267–271 (2012). [DOI] [PubMed] [Google Scholar]
- 10.Goo H. W. CT radiation dose optimization and estimation: an update for radiologists. Korean J. Radiol. 13, 1–11 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Deak P. D., Smal Y., Kalender W. A. Multisection CT protocols: sex and age-specific conversion factors used to determine effective dose from dose-length product. Radiology. 257, 158–166 (2010). [DOI] [PubMed] [Google Scholar]
- 12.Huda W., Magill D., He W. CT effective dose per dose length product using ICRP 103 weighting factors. Med. Phys. 38, 1261–1265 (2011). [DOI] [PubMed] [Google Scholar]
- 13.Korir G. K., Wambani J. S., Korir I. K., Tries M. A., Mulama B. N. Quality management systems in radiology. S. Afri. J. Radiol. 17(3), 84–88 (2013). [Google Scholar]
- 14.Galanski M., Nagel H. D., Stamm G. Paediatric CT exposure practice in the federal republic of Germany: results of a nationwide survey in 2005–2006. Medizinische Hochschule; (2007). [Google Scholar]
- 15.Verdun F. R., Gutierrez D., Vader J. P., Aroua A., Alamo-Maestre L. T., Bochud F., Gudinchet F. CT radiation dose in children: a survey to establish age-based diagnostic reference levels in Switzerland. Eur. Radiol. 18, 1980–1986 (2008). [DOI] [PubMed] [Google Scholar]
- 16.Shrimpton P. C., Hillier M. C., Lewis M. A., Dunn M. National survey of doses from CT in the UK: 2003. Br. J. Radiol. 79, 968–980 (2006). [DOI] [PubMed] [Google Scholar]
- 17.Bongartz G., et al. European Guidelines for Multislice Computed tomography. FIGM-CT2000-20078-CT-TIP European Commission, (2004). [Google Scholar]
- 18.Shrimpton P. C., Hillier M. C., Lewis M. A., Dunn M. Doses from Computed Tomography (CT) Examinations in the UK—2003 Review. NRPB Report -W67 NRPB, (2005). [Google Scholar]
- 19.Shrimpton P. C., Wall B. F. Reference doses for paediatric computed tomography. Radiat. Prot. Dosim. 90, 249–252 (2000). [Google Scholar]
- 20.Fukushima Y., Tsushima Y., Takei H., Taketomi-Takahashi A., Otake H., Endo K. Diagnostic reference level of computed tomography (CT) in Japan. Radiat. Prot. Dosim. 151, 51–57 (2012). [DOI] [PubMed] [Google Scholar]
- 21.Yakoumakis E., Karlatira M., Gialousis G., Dimitriadis A., Makri T., Georgiou E. Effective dose variation in pediatric computed tomography: dose reference levels in Greece. Health Physics. 97, 595–603 (2009). [DOI] [PubMed] [Google Scholar]
- 22.European Commission (EC). European guidelines on quality criteria for computed tomography. EUR 16262, Luxembourg (1999).
- 23.Palorini F., Origgi D., Granata C., Matranga D., Salerno S. Adult exposures from MDCT including multiphase studies: first Italian nationwide survey. Eur Radiol. 24(2), 469–483 (2013). [DOI] [PubMed] [Google Scholar]
- 24.Foley S. J., McEntee M. F., Rainford L. A. Establishment of CT diagnostic reference levels in Ireland. Br. J. Radiol. 85, 1390–1397 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Yates S. J., Pike L. C., Goldstone K. E. Effect of multislice scanners on patient dose from routine CT examinations in East Anglia. Br. J. Radiol. 77, 472–478 (2004). [DOI] [PubMed] [Google Scholar]
- 26.Treier R., Aroua A., Verdun F. R., Samara E., Stuessi A., Trueb Ph. R. Patient doses in CT examinations in Switzerland: implementation of national diagnostic reference levels. Radiat. Prot. Dosim. 142, 244–253 (2010). [DOI] [PubMed] [Google Scholar]
- 27.Kharita M. H., Khazzam S. Survey of patient dose in computed tomography in Syria 2009. Radiat. Prot. Dosim. 141, 149–161 (2010). [DOI] [PubMed] [Google Scholar]
- 28.Heggie J. C. P. Patient doses in multi-slice ct and the importance of optimization. Australas. Phys. Eng. Sc. Med. 28, 86–96 (2005). [DOI] [PubMed] [Google Scholar]
- 29.Mettler F. A., Jr., Huda W., Yoshizumi T. T., Mahesh M. Effective doses in radiology and diagnostic nuclear medicine: a catalog. Radiology. 248, 254–263 (2008). [DOI] [PubMed] [Google Scholar]
- 30.Nawfel R. D., Judy P. F., Schleipman A. R., Silverman S. G. Patient radiation dose at CT urography and conventional urography. Radiology. 232, 126–132 (2004). [DOI] [PubMed] [Google Scholar]
- 31.Caoili E. M., Cohan R. H., Korobkin M., Platt J. F., Francis I. R., Faerber G. J., Montie J. E., Ellis J. H. Urinary tract abnormalities: initial experience with multi-detector row CT urography. Radiology. 222, 353–360 (2002). [DOI] [PubMed] [Google Scholar]
- 32.Hausleiter J., Meyer T., Hadamitzky M., Huber E., Zankl M., Martinoff S., Kastrati A., Schomig A. Radiation dose estimates from cardiac multislice computed tomography in daily practice: impact of different scanning protocols on effective dose estimates. Circulation. 113, 1305–1310 (2006). [DOI] [PubMed] [Google Scholar]
- 33.Muhogora W. E., et al. Patient doses in CT examinations in 18 countries: initial results from International Atomic Energy Agency projects. Radiat. Prot. Dosim. 136, 118–126 (2009). [DOI] [PubMed] [Google Scholar]
- 34.Dosimetry working party of the Institute of Physical Sciences in Medicine (IPSM). National protocol for patient dose measurements in diagnostic radiology. NCRB, (1992). [Google Scholar]
- 35.IAEA (International Atomic Energy Agency). Dosimetry in diagnostic radiology: an international quality assurance manual. Technical Report Series No. 457 IAEA, (2007). [Google Scholar]
- 36.Hart D., Wall B. Radiation exposure of the UK population from medical and dental x-ray examinations. NRPB-W4, NCRB, (2002). [Google Scholar]
- 37.Strauss K. J., Goske M. J., Kaste S. C., Bulas D., Frush D. P., Butler P., Morrison G., Callahan M. J., Applegate K. E. Image gently: ten steps you can take to optimize image quality and lower CT dose for pediatric patients. Am. J. Roentgenol. 194, 868–873 (2010). [DOI] [PubMed] [Google Scholar]
- 38.Vassileva J., et al. IAEA survey of pediatric CT practice in 40 countries in Asia, Europe, Latin America, and Africa: Part 1, frequency and appropriateness. Am. J. Roentgenol. 198, 1021–1031 (2012). [DOI] [PubMed] [Google Scholar]
- 39.Ngaile J. E., Msaki P., Kazema R. Towards establishment of the national reference diagnostic levels from computed tomography examinations in Tanzania. J. Radiol. Prot. 26, 213–225 (2006). [DOI] [PubMed] [Google Scholar]
- 40.Wambani J. S., Korir G. K., Korir I. K., Kilaha S. Establishment of local diagnostic reference levels in paediatric screen-film radiography at a children's hospital. Radiat Prot Dosimetry. 154(4), 465–476 (2013). [DOI] [PubMed] [Google Scholar]



